EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India

Varun Dhir, Shung Ming Chiu, Rajiva Gupta, Shery Susan Phillip, Padmanabha Shenoy, Bharati Taksande, Dhiren Rawal, Kuldeep Kumar, Gargi Singh, Sandeep Kumar, Shahzeene Dhuria, Anuroopa Manovihar und 4 weitere

Journal of The Association of Physicians of India · 2024

DOI: 10.59556/japi.72.0756 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of The Association of Physicians of India, 2024. Verfasst von Varun Dhir und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine (Division of Rheumatology), Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, Co…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Antirheumatic Agents. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAntirheumatic AgentsHumansFemaleMaleCross-Sectional StudiesIndiaMiddle AgedAdultDrug Therapy, CombinationMethotrexate

Substanzen

Antirheumatic AgentsMethotrexate

Autor:innen und Institutionen

  • Department of Internal Medicine (Division of Rheumatology), Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, Corresponding Author.
  • Department of Internal Medicine (Division of Rheumatology), Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Department of Clinical Immunology and Rheumatology, Medanta Institute of Education and Research (MIER), Gurugram, Haryana, India.
  • Department of Clinical Immunology and Rheumatology, St John's Medical College and Hospital (SJMCH), Bengaluru, Karnataka, India.
  • Department of Clinical Immunology and Rheumatology, Centre of Arthritis and Rheumatism Excellence (CARE), Cochin, Kerala, India.
  • Department of Medicine, Mahatma Gandhi Institute of Medial Sciences (MGIMS), Wardha, Maharashtra, India.

Zitieren

APA

Dhir, V., Chiu, S. M., Gupta, R., Phillip, S. S., Shenoy, P., Taksande, B., Rawal, D., Kumar, K., Singh, G., Kumar, S., Dhuria, S., Manovihar, A., Bhagat, A., Soni, C., Jain, S., & Shobha, V. (2024). Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India. Journal of The Association of Physicians of India. https://doi.org/10.59556/japi.72.0756

Vancouver

Dhir V, Chiu SM, Gupta R, Phillip SS, Shenoy P, Taksande B, et al. Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India. Journal of The Association of Physicians of India. 2024. doi:10.59556/japi.72.0756

BibTeX
@article{Dhir2024,
  author = {Dhir, Varun and Chiu, Shung Ming and Gupta, Rajiva and Phillip, Shery Susan and Shenoy, Padmanabha and Taksande, Bharati and Rawal, Dhiren and Kumar, Kuldeep and Singh, Gargi and Kumar, Sandeep and Dhuria, Shahzeene and Manovihar, Anuroopa and Bhagat, Apoorva and Soni, Chaitanya and Jain, Sanjay and Shobha, Vineeta},
  title = {Conventional Synthetic Disease-modifying Drugs Remain the Mainstay of Therapy for Rheumatoid Arthritis in India},
  journal = {Journal of The Association of Physicians of India},
  year = {2024},
  doi = {10.59556/japi.72.0756}
}
Kostenlos starten →